LEXX financials
Lexaria Bioscience (LEXX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- LEXX revenue was $705.92K in fiscal 2025, net income -$11.90M.
LEXX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $705.92K | $703.20K | -$11.88M | -$11.90M | -0.66 |
| 2024 | $464.28K | $459.46K | -$5.75M | -$5.80M | -0.47 |
| 2023 | $226.21K | $194.71K | -$6.53M | -$6.66M | -1.01 |
| 2022 | $255.40K | $183.56K | -$6.62M | -$7.27M | – |
| 2021 | $722.74K | $547.39K | -$5.69M | -$4.03M | -0.95 |
| 2020 | $314.79K | $215.41K | – | -$3.93M | -1.47 |